FBInvestor
Stocks / Moonlake Immunotherapeutics
Institutional Ownership

Moonlake Immunotherapeutics

CUSIP 61559X104CLASS A ORDMLTXQ1 2026

Dividends

Dividends-per-share are sourced from SEC XBRL filings. Either this issuer doesn't declare a common dividend, or it isn't ingested yet (we cover the top issuers first).

Coming soon